Keybanc Maintains Overweight Rating for Repligen: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Keybanc has maintained its Overweight rating for Repligen (NASDAQ:RGEN) but lowered its price target from $240.00 to $210.00. Repligen's shares are currently trading at $134.55, indicating a potential increase of 56.08% if the price target is met.
November 01, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Keybanc has maintained its Overweight rating for Repligen but lowered its price target. This suggests that while Keybanc remains bullish on Repligen, it has adjusted its expectations for the stock's future performance.
The news is directly about Repligen and its rating by Keybanc. The maintenance of the Overweight rating indicates that Keybanc still believes Repligen's stock will outperform the market, which is positive for the stock. However, the lowering of the price target may indicate a tempering of expectations, which could have a mixed impact. Overall, the impact is likely to be positive in the short term as the Overweight rating is maintained.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100